Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) was the recipient of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 804,000 shares, an increase of 40.6% from the February 13th total of 571,900 shares. Based on an average daily trading volume, of 412,700 shares, the short-interest ratio is currently 1.9 days. Currently, 4.9% of the company’s stock are short sold.
Cosmos Health Price Performance
COSM opened at $0.50 on Tuesday. The business’s 50-day moving average is $0.65 and its two-hundred day moving average is $0.75. Cosmos Health has a 1 year low of $0.44 and a 1 year high of $1.58. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24. The firm has a market capitalization of $11.72 million, a PE ratio of -0.21 and a beta of 5.60.
Insider Activity
In other news, CEO Grigorios Siokas purchased 257,334 shares of the business’s stock in a transaction dated Friday, December 20th. The shares were purchased at an average price of $0.58 per share, for a total transaction of $149,253.72. Following the completion of the purchase, the chief executive officer now owns 3,774,314 shares in the company, valued at approximately $2,189,102.12. This represents a 7.32 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Georgios Terzis bought 85,778 shares of the business’s stock in a transaction on Friday, December 20th. The stock was bought at an average price of $0.58 per share, for a total transaction of $49,751.24. Following the purchase, the chief financial officer now directly owns 727,263 shares of the company’s stock, valued at $421,812.54. The trade was a 13.37 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 1,175,618 shares of company stock worth $701,169. Company insiders own 15.61% of the company’s stock.
Hedge Funds Weigh In On Cosmos Health
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Featured Articles
- Five stocks we like better than Cosmos Health
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Can TikTok Stock Picks Really Make You Rich?
- How Technical Indicators Can Help You Find Oversold StocksĀ
- The “Quality” Rotation: Back to Basics Investing
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.